Annals of the New York Academy of Sciences 1997: Vol 838 Index

7 Pages·1997·0.62 MB·English

Subject Index
.^^hst)rhcr concentration, determination Diffusion theory, definition of. 1
of. 8t) Dual-site spectroscopy, equation for. 82
Aliiorithm Dual-wavelength spectroscopy, equation
binary decision. 110 for. 82
diagnostic decision. 110 Dysplasia, diagnosis of. with DNF. 118
Algorithm development. lO.S Dysplastic lesion, colonic mucosa. 112
(5-Amino levulinic acid. Ppl.X tissue
sensitization and. 12.^-124. 1.40
Angiogenesis. 18.4 E^lectronic time gate. 10
Architectural features, malignant Ensemble of photons, unconstrained
melanoma. 14.4 classical path for. 0
Esophageal cancer. EIF and. 116
Excitation wavelength, dependence of
Beer-Lambert law. optical quantitation of
LIAFS on. r.4()
absorbers based on. 7.4
Bone, optical biopsy of. 68
Breast Fertility, restoration of. 71
normal human female. 171 Fiber optic coupler. OCT system and.
normal vs tumor-bearing. .41 00
Bronchoscopy. 104 Fibroadenoma, breast. 180
Fibrocystic disease. 181)
C^aneer. head and neck. ALA-indueed Fluence rate, probability and. 6
PplX lluoreseenee and. 126 Fluorescence
Cancer years, normal female breast in. 172 tissue. 100
Carcinoma ultra-weak. 104
breast. 184 Fluorescence emission spectrum.
classification of. with DNF. 118 measurements of. 64
Carcinoma in situ. LIAFS and. 1.40 Fluorescence lifetime spectroscopic
Cell cluster optics. 104 imaging. 46
Clinical impact, optical biopsy, three Fluorescence polarization difference
scenarios of. 72 imaging. 20
Clinical measurements. LIF and. 117 Fluorophores
Colleet4)r. photons arriving early at. 1 exogenous. 188
Colon spectra. 110 most important. 14.4
Colonoscopy. 104 naturally occurring, breast. 177
Concentration, quantitation of changes in. Frequency domain response, system
86 function and. 70
(\)nfoeal mieroseopv. optical biopsv and. Frequency domain photon migration
40 multi-pixel measurements of. .40
Constrained classical path, photon velocity single-pixel measurements of. 48
and. 7 Functional images. FRS. 47
Continuous light. NIR images using. 20
Contrast aiient dvnamies. .41
Cr^ iMg.s'iOj laser. 101 Ciroup path, ensemble of photons and. 0
Cystoscopy. 104
Cytokeratin. optical biopsy of. 1.40
Hemorrhage and biopsy, breast. 188
Cvtolonieal features, malittnant melanoma.
High-speed and high-resolutitm OCT. 04
"144
Histology, limitations of. 108
Desmoplasia, breast carcinoma and. 188
Diagnostic applications, laser. 104 Immune response. 184
Differential normalized lluoreseenee Impulse response, temporal intenration of.
method, laser-induced. 118 78
2(NI ANNAI.S NKW ^OKK At ADKMY OK St IK.NCKS
In I'iro human skin, nuiltiphoton excitation Optical computeri/ed tomography, new
microscopy of. .SS approach to. 7.4
Inllammation. IS.^ Optically active components, breast. 174
Intravascular ultrasound catheter. OC T
cathctcr-cndoscopc and. 1(U
Inversion aluorithm. I'l.l and. .>4 Path integral method, basic idea ol. 2
Pathology correlations, optical biopsy
techniques and. 144
I^cratin lilamcnts. intermediate. 1.''2 Phase modulation spectroscopy, equation
Kerr-Fourier imaijing system. IS for. S2
Phase-modulated liiiht. NIR imaiies usinu.
29 '
Laser-induced autolluoreseenee
spectroscopy, excitation wavelenuth Phased array image. 42
in. 1.40 Phased array locali/ation. .4.S
L.aser-indueed lluoreseenee. cancer and Photon, scattering media and. 1.4
dysplasia diagnosis with. I Ih Photon migration, measurements of. 4b
Laser-induced spectroscopic methods, tissue Photon transport, probability of. 2
charaeteri/ation and. 12.4 Prepubertal development, breast. 172
Light ahsorhers. breast. I7(i Probability, photon transport and. 2
Light seatterers. breast. I7.4 Protoporphyrin l\ tissue sensitization. 124.
1.40 ’
Lost positional sensitivity. .4S
Low-coherence interlerometrv. schematic Pulsed light. NIR images using. 29
of. *^7
M ^Quantitation of absorbers. 74
■ignetie resonance imaging, contrast in.
29
l^econstruetion of (’ T image. S.4. S9
Malignant melanoma, architectural and
Rescaling procedure, physical basis of. IbO
eytologieal features of. 144
Medical applications, time-resolved and
nonlinear optical imaging for. 14 Scattering media, photon in. 14
Monte Carlo simulations Shadtivvgram. transillumination imaging
definition of. I technique and. 14
squamous cell carcinoma and. 1.49 Single-pixel measurements. FDPM and. S4
Mucosal dysplasia, lluoreseenee and. 1(19 Skin anatomy. 48
Multiphoton excitatit)n microscopy. Skin autolluoresenee. 49
lluoreseenee imaging vs. Ml Solid state laser sources. 102
Multipholon scanning microscope. b2 Spectral pathology. lOS
Multi-pixel measurements. FDPM and. .4(1 Squamous carcinoma, desmosomea in. 144
Squamous epithelium, mullicellular. 141
^Jear-infrared images, continuous, phase- Stand-alone device, breast sudy by. 42
modulated. and pulsed light and. 29 Superluminescent diodes. OC F and. 9S
Nicotinamide adenine dinucleotide, reduced
form of. 1.4(1
Temporal integration, impulse response
Nonlinear optical subsurface mapping
and. 7S
methods. 24
Temporal integration spectroscopy.
Nuclear magnetic resonance, contrast in. 29
equation for. SI
lestis. optical biopsy of. bS
Optical body scanning, scope of. 17 Therapeutic applications, laser. 194
Optical coherence tomography I i: Al (). laser. 9S
high-speed and high-resolution. 9.4 Time-resolved methods. 17
optical biopsy with. bS Time-resolved spectroscopy
Optical coherence tomography catheter- equation (or. SI
endosci)pe for transverse imaging, second (unior conirasi and. 44
schematic of. 10.4 Tissue characterization, laser-induced
Optical coherence tomography system, spectroscopic methods in. 124
schematic of. 70 Tissue morphology. 194
201
l omographic image, reconstruclion of. S.^. Turbid media, optieal quantitation of
'.S9 absorbers in. 15
Tumor Two-photon excitation microscopy, bl
bladder. I.IAFS and. l.TO
eontrast agents lor. .T2
nonmelanoma malignant skin. 124 Itrasound. Oct vs, M
urinary bladder. 124 Unconstrained classical path, ensemble of
Tumor border /one. I.'^O photons and. 0
__I—
Index of Contributors
Klintcbcrg. 123-129 N^anoharan. R.. 108-113
Alfani), R. rI xi-xii. 14-28. 194. 197 Masters. B. R.. .38-67
AndcrssDn-Encels. S.. 123-129 Minel. O.. 1.30-170
Anidjar. M.. 1.30-142 Muller. G.. 1.30-170
Avillicr. S.. 1.30-142
Nilsson. A.. 12.3-129
Bculhan. J.. l.SO-170. 194
Bopparl. S. A.. 68-74. 9.S-107 Overholt. B. F.. 116-122
Bounia. B.. 68-74. 9.3-107
Paithankar. D. Y.. 46-37
Brc/inski. M E.. 68-74. 9.S-107
Panjehpour. M., 116-122
Pitris. C.. 68-74. 93-107
Chance. B.. 29-4.3
('olhren. R.. 108-113 R.eynolds. J. S.. 46-37
Crawlord. J. M.. 108-113 Reynolds. W. A., ix-x
('usscnot. ().. 130-142
Sevick-Muraca. E. M.. 46-37
Demos. S. (i.. 14-28 So, P. T. C.. 38-67
Southern. J. F.. 68-74. 93-107
Eltori. D.. 1.30-142 Svanberg. K.. 12.3-129
Svanberg, S.. 123-129
Feld. M. S.. 108-113. 194 Xatman, D.. 171-193
Eit/maurice. \1.. 108-113 Tearnev. G. J.. 68-74. 93-107
FK)tte. T. .1.. 143-149. 194-193 Teillac. P.. 1.30-142
Eujimolo. .1. (i.. 68-74. 93-107. 193 Thomsen. S.. 171-19.3. 19.3-196
Tomaselli. V. P.. 194
Galland. B.. 14-28 Troy, T. L.. 46-37
(layen. S. K.. 14-28 Tsuchiya. Y., 73-94
(iratlon. E.. 38-67
(iuo. Y.. 14-28 U rakami, T., 73-94
Ho. P. P.. 14-28 an Dam. J.. 108-113
Vo-Dinh, T.. 116-122
J acques. S. L.. 1-13 Wang. L. 12.3-129
L.
Wang. 14-28
Le Due. A.. 1.30-142 Wang. O. Z.. 14-28
Eiaim. X.. 14-28 Wang. W. B., 14-28
Liu. F.. 14-28 z
Lope/. (L. 46-37 onios. G.. 108-113
203